Analgesics and Nonsteroidal Anti-Inflammatory Drugs

  • A. Szczeklik
Chapter
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 63)

Abstract

The scarcity and high price of quinine during the last third of the nineteenth century motivated the search for synthetic antipyretics. As a result, a large number of compounds were introduced into medicine which share with cinchona the ability to produce antipyretic, analgesic, and anti-inflammatory effects (Woodbury and Fingl 1979). Of these, aspirin has become the most widely used drug in the world. Recently, there have been main reasons for the research in this area. First, the recognition of the value and the limitations of the adrenocorticosteroids for long-term therapy of inflammatory disorders. Second, the new possibilities of employing aspirin-like drugs in prevention and therapy of thromboembolic diseases.

Keywords

Allergy Clin Immunol Nasal Polyp Chronic Urticaria Mefenamic Acid Analgesic Nephropathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackroyd JF (1964) The diagnosis of disorders of the blood due to drug hypersensitivity caused by an immune mechanism. In: Ackroyd JF (ed) Immunological methods. Black-well, OxfordGoogle Scholar
  2. Adcock JJ, Garland LG, Moncada S, Salmon JA (1978) The mechanism of enhancement by fatty acid hydroperoxides of anaphylactic mediator release. Prostaglandins 16:179–189PubMedGoogle Scholar
  3. Amos HE (1976) Allergic drug reactions. Arnold, LondonGoogle Scholar
  4. Anonymous (1974) Aspirin-induced hepatic injury. Ann Intern Med 80:103–105Google Scholar
  5. Anonymous (1979) Liver injury, drugs, and popular poisons. Br Med J 2:574–575Google Scholar
  6. Argov Z, Mastaglia (1979) Drug-induced peripheral neuropathies. Br Med M 1:663–665Google Scholar
  7. Badley BWD (1979) Phenazopyridine-induced hepatitis. Br Med J 2:850Google Scholar
  8. Barrett AJ, Weller E, Rozengurt N, Longhurst P, Humble JG (1976) Amidopyrine agranulocytosis: drug inhibition of granulocyte colonies in the presence of patient’s serum. Br Med J 2: 850–851PubMedGoogle Scholar
  9. Basomba A, Romar A, Villamanzo, IG, Campos A (1976) The effect of sodium cromoglycate in preventing aspirin-induced bronchospasm. Clin Allergy 6:269–275PubMedGoogle Scholar
  10. Bianco S, Robuschi M, Petrigni C (1977) Aspirin-induced tolerance in aspirin-asthma detected by a new challenge test. IRCS Med Sci Libr Compend 5:129Google Scholar
  11. Borgeat P, Samuelsson B (1979) Arachidonic acid metabolism in polymorphonuclear leukocytes. 3. Effects of ionophore — A 23187. Proc Natl Acad Sci USA 76:2148–2153PubMedGoogle Scholar
  12. Brocq L (1894) Éruption érythèmato-pigmentée fixé due à l’antipyrine. Ann Dermatol Syphiligr 5:308–314Google Scholar
  13. Bundgaard H (1976) Colorimetric analysis of immunogenic impurities in acetylsalicylic acid. J Pharm Pharmacol 28:544–547Google Scholar
  14. Bundgaard H, de Weck AL (1975) The role of aminoreactive impurities in acetylsalicylic acid allergy. Int. Arch Allergy Appl Immunol 49:119–125Google Scholar
  15. Burka JF, Flower RJ (1979) Effects of modulators of arachidonic acid metabolism on the synthesis and release of slow-reacting substances of anaphylaxis. Br J Pharmacol 65:35–41PubMedGoogle Scholar
  16. Ceserani R, Colombo M, Robuschi M, Bianco S (1978) Tartrazine and prostaglandin system. Prostaglandins Med 1:499–505PubMedGoogle Scholar
  17. Chafee FH, Settipane GA (1974) Aspirin intolerance. I. Frequency in an allergic population. J Allergy Clin Immunol 53:193Google Scholar
  18. Czerniawska-Mysik G, Szczeklik A (1980) Allergy to pyrazolone drugs. Acta Med PolGoogle Scholar
  19. Delaney JC (1973) Asthma, nasal polyposis and aspirin sensitivity. Ann Intern Med 79:761PubMedGoogle Scholar
  20. Delaney JC (1976) The effect of sodium cromoglycate on analgesic-induced asthmatic reactions. Clin Allergy 6:365–370PubMedGoogle Scholar
  21. Delaney JC, Kay AB (1976) Complement components and IgE in patients with asthma and aspirin idiosyncrasy. Thorax 31:425–427PubMedGoogle Scholar
  22. D’Eshouges JR, Grigner P, Smadja A et al. (1961) Purpura thrombocytopenique aigü par sensibilisation à l’aspirine. Nouv Rev Fr Hematol 1:609–611Google Scholar
  23. de Weck AL (1971) Immunological effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations. Int Arch Allergy Appl Immunol 41:393–398PubMedGoogle Scholar
  24. Doeglas HMG (1975) Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 93:135–141PubMedGoogle Scholar
  25. Drazen JM, Lewis RA, Wasserman SI, Orange RP, Austen FK (1979) Differential effects of a partially purified preparation of slow-reacting substance of anaphylaxis on guineapig tracheal spirals and parenchymal strips. J Clin Invest 63:1–5PubMedGoogle Scholar
  26. Dry J, Pradalier A, Deveau A (1979) Urticaire et oedème de Quincke chroniques. Nouv Presse Med 8:211PubMedGoogle Scholar
  27. Falliers C (1974) Familial coincidence of asthma, aspirin intolerance and nasal polyposis. Ann Allergy 32:65–69PubMedGoogle Scholar
  28. Farr RS (1971) The capacity of aspirin to acetylate proteins in vitro and in vivo. In: Aldridge WN (ed) Mechanisms of toxicity. St. Martin, New YorkGoogle Scholar
  29. Ferreira SH, Moncada S, Vane JR (1971) Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature New Biol 231:237–239PubMedGoogle Scholar
  30. Fisherman EW, Cohen GN (1974) Alpha-beta adrenergic imbalance in intrinsic-intolerance rhinitis or asthma. Ann Allergy 33:86–101PubMedGoogle Scholar
  31. Flandrin G, Daniel MT, Briere J, Varet B, Pestel M, Bernard J (1971) L’agranulocytose au pyramidon, une aplasie bréve de trois lignés. Nouv Rev Fr Hematol 11:219–221PubMedGoogle Scholar
  32. Flower RJ (1974) Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 26:33–67PubMedGoogle Scholar
  33. Flower RJ, Blackwell GJ (1979) Anti-inflammatory steroids induce the biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456–459PubMedGoogle Scholar
  34. Garg S, Sarker CR (1974) Aspirin-induced thrombocytopenia on an immune basis. Am J Med Sci 267:129–131PubMedGoogle Scholar
  35. Gerber JG, Payne NA, Oelz O, Nies AS, Oates JA (1979) Tartrazine and the prostaglandin system. J Allergy Clin Immunol 63:289–294PubMedGoogle Scholar
  36. Giraldo B, Blumenthal MN, Spink WW (1969) Aspirin intolerance and asthma. Ann Intern Med 71:479–485PubMedGoogle Scholar
  37. Goldberg M, Murray TG (1978) Analgesic-associated nephropathy. N Engl J Med 299:716–717PubMedGoogle Scholar
  38. Gross R, Hellriegel KP (1976) Arzneimittelbedingte Agranulozytosen. Blut 32:409–414PubMedGoogle Scholar
  39. Gryglewski RJ (1976) Steroid hormones, anti-inflammatory steroids and prostaglandins. Pharmacol Res Commun 8:337–351PubMedGoogle Scholar
  40. Gryglewski RJ (1979) Screening and assessment of potency of anti-inflammatory drugs in vitro. In: Vane JR, Ferreira SH (eds) Anti-inflammatory drugs. Handbook of experimental pharmacology, Springer-Verlag, Berlin Heidelberg New York, vol 50/2, pp 1–43Google Scholar
  41. Gryglewski RJ, Szczeklik A (1978) Inhibition of prostaglandin formation by lipid peroxides in the arterial wall: hypothetical step in development of atherosclerosis. Mater Med Pol 37:338–341Google Scholar
  42. Gryglewski RJ, Panczenko B, Korbut R, Grodzińska L, Ocetkiewicz A (1975 a) Corticosteroids inhibit prostaglandin release from perfused lungs of sensitized guinea pigs. Prostaglandins 10:343–355PubMedGoogle Scholar
  43. Gryglewski RJ, Szczeklik A, Czerniawska-Mysik G (1975b) Aspirin sensitivity: other drugs. Ann Intern Med 83Google Scholar
  44. Gryglewski, RJ, Dembińska-Kieć, A, Grodzińska L, Panczenko B (1976) Differential generation of substances with prostaglandin-like and thromboxane-like activities by guinea pig trachea and lung strips. In: Bouhuys A (ed) Lung cells in disease. North Holland, Amsterdam Oxford New York, pp 289–307Google Scholar
  45. Gryglewski RJ, Szczeklik A, Niżankowska E (1977) Aspirin-sensitive asthma: its relationship to inhibition of prostaglandin biosynthesis. NATO Adv Study Inst Ser A Life Sci 13:191–203Google Scholar
  46. Gwin E, Kerby GR, Ruth WE (1977) Cromolyn sodium in the treatment of asthma associated with aspirin hypersensitivity and nasal polyps. Chest 72:148–154PubMedGoogle Scholar
  47. Harnett JC, Spector SL, Farr RS (1978) Aspirin idiosyncrasy. In: Middleton E Jr, Reed CE, Ellis EF (eds) Allergy. Principles and practice. Mosby, St. Louis, pp 1002–1022Google Scholar
  48. Hennemann HH, Schief A (1975) Rezidive von Agranulozytose. Dtsch Med Wochenschr 100:519–522PubMedGoogle Scholar
  49. Hume M, Eddy V (1977) Treatment of chronic airways obstruction with indomethacin. Scan J Respir Dis 58:284–286Google Scholar
  50. Irey NS (1976) Adverse drug reactions and death. JAMA 236:575–578PubMedGoogle Scholar
  51. Jacob HS, Jandl JH (1962) Effects of sulfhydrol inhibition on red blood cells. J Clin Invest 41:779–790PubMedGoogle Scholar
  52. Jeannet M, Lew D, Legendre C (1979) Amidopyrine pancytopenia: detection of leuco-cytotoxic antibodies by a 51Cr-release test. Acta Haematol (Basel) 61:52–54Google Scholar
  53. Juhlin L, Michaëlsson G, Zetterström O (1972) Urticaria and asthma induced by food-and-drug additives in patients with aspirin hypersensitivity. J Allergy Clin Immunol 50:92–98PubMedGoogle Scholar
  54. Kaplan AP (1978) Urticaria and angioedema. In: Middleton E Jr, Reed CE, Ellis EF (eds) Allergy. Principles and practice. Mosby, St. Louis, pp 1080–1099Google Scholar
  55. Karpatkin S (1971) Drug-induced thrombocytopenia. Am J Clin Sci 262:69–78Google Scholar
  56. Kaufman HS (1977) Nasal polyps, syncope and asthma. Lancet 1:758PubMedGoogle Scholar
  57. Kincaid-Smith P (1978) Analgesic nephropathy. Kidney Int 13:1–113PubMedGoogle Scholar
  58. Klatskin G (1974) Drug-induced hepatic injury. In: Schaffner F, Sherlock S, Leevy CM (eds) The liver and its diseases. Intercontinental Medical Books, New York, pp 163–178Google Scholar
  59. Kordansky D, Adkinson F, Norman PS, Rosenthal RR (1978) Asthma improved by non-steroidal anti-inflammatory drugs. Ann Intern Med 88:508–511PubMedGoogle Scholar
  60. Leist ER, Banwell JG (1974) Products containing aspirin. N Engl J Med 291:710–713PubMedGoogle Scholar
  61. Lockey RF, Rucknagel DL, Vaneslow NA (1973) Familial occurrence of asthma and nasal polyps and aspirin intolerance. Ann Intern Med 78:57–63PubMedGoogle Scholar
  62. Lockey SD (1977) Hypersensitivity to tartrazine (FD C Yellow No. 5) and other dyes and additives present in foods and pharmaceutical products. Ann Allergy 38:206–210PubMedGoogle Scholar
  63. Maddsey WC, Boitnott JK (1977) Drug-induced chronic liver disease. Gastroenterology 72:1348–1353Google Scholar
  64. Mandell B, Shen HS, Hepburn B (1976) Fever from ibuprofen in a patient with lupus erythematosus. Ann Intern Med 85–209–210PubMedGoogle Scholar
  65. Martelli NA, Usandivaras G (1977) Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation. Thorax 32:684–690PubMedGoogle Scholar
  66. Matthews JI, Stage D (1974) Indomethacin, aspirin and urticaria. Ann Intern Med 80:771PubMedGoogle Scholar
  67. Matthews KP, Lowell RG, Sheldon JM (1950) The problem of aspirin allergy with a report on skin testing with salicylate containing human sera J Lab Clin Med 36:416–419Google Scholar
  68. McDonald JR, Mathison DA, Stevenson DD (1972) Aspirin intolerance in asthma. J Allergy Clin Immunol 50:198–207PubMedGoogle Scholar
  69. Michaëlsson G (1969) Chronic urticaria. Acta Derm venereol (Stockh) 49:404–416Google Scholar
  70. Mihatsch MJ, Zollinger HU, Torhorst J (1979) Pathognomonic lesion of analgesic nephropathy. E Engl J Med 300:1275–1276Google Scholar
  71. Miller RL, Insel PA, Melmon KL (1978) Inflammatory disorders. In: Melmon KL, Morelli WF (eds) Clinical pharmacology, 2nd edn. Macmillan, New York, pp 657–708Google Scholar
  72. Moeschlin S (1954) Weitere Beobachtungen über Immunleukopenien und Agranulozytosen. Schweiz Med Wochenschr 84:1100–1103PubMedGoogle Scholar
  73. Moeschlin S, Wagner K (1952) Agranulocytosis due to the occurrence of leukocyte agglutinins (pyramidon and cold agglutinins). Acta Haematol (Basel) 8:29–41Google Scholar
  74. Molaney JR (1977) Nasal polyps, nasal polypectomy, asthma and aspirin sensitivity. J Laryngol Otol 91:837–846Google Scholar
  75. Moore-Robinson M, Warin RP (1967) Effect of salicytaes in urticaria. Br Med J 4:262–266PubMedGoogle Scholar
  76. Nieweg HO, Bouma HGD, Vries KD (1963) Hematological side effects of some antirheumatic drugs. Ann Rheum Dis 22: 440–443PubMedGoogle Scholar
  77. Nizankowska E, Szczeklik A (1979) Keine Bedenken gegen Solosin bei Acetylsalicylsäure-empfindlichen Asthmatikern. Dtsch Med Wochenschr 104:1388–1389PubMedGoogle Scholar
  78. Noid HE, Schulze TW, Winkelmann RK (1974) Diet plan for patients with salicylate-in-duced urticaria. Arch Dermatol 109:666–670Google Scholar
  79. O’Brien JR (1968) Effects of salicylates on human platelets. Lancet 1:779–781PubMedGoogle Scholar
  80. Okazaki T, Ilea VS, Rosario NA, Reisman RE, Arbesman CE, Lee JB, Middleton E Jr (1977) Regulatory role of prostaglandin E in allergic histamine release with observations on responsiveness of basophil leukocytes and the effect of acetylsalicylic acid. J Allergy Clin Immunol 60:360–366PubMedGoogle Scholar
  81. Orehek J, Douglas JS, Bouhuys A (1975) Contractile responses of the guinea pig trachea in vitro: modification by prostaglandin synthesis-inhibiting drugs. J Pharmacol Exp Ther 194:554–564PubMedGoogle Scholar
  82. Panczenko B, Grodzinska L, Gryglewski RJ (1975) The dual action of meclofenamate or contractive response to PGF2 in the guinea pig trachea. Pol J Phamacol Pharm 27:273–278Google Scholar
  83. Pasargiklian M, Bianco S, Allegra L, Moavero NE, Petrigni C, Robuschi M, Grugni A (1977) Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration 34:79–91Google Scholar
  84. Patrono C, Ciabattoni G, Venuti A, Pugliese F, Schiavino D, Patriarca G (1978) Aspirin intolerance: unaltered susceptibility of platelet cyclo-oxygenase to inhibition by aspirin in vitro. J Allergy Clin Immunol 62:271–275PubMedGoogle Scholar
  85. Prescott LF, Newton RW, Swainson CP, Wright N, Forrest ARW, Matthew H (1974) Successfull treatment of severe paracetamol overdosage with cysteamine. Lancet 1:588–592PubMedGoogle Scholar
  86. Quick AJ (1966) Salicylates and bleeding. The aspirin tolerance test. Am J Med Sci 252:268–270Google Scholar
  87. Rachelefsky GS, Carlson A, Siegel CS, Stiehm ER (1975) Aspirin intolerance in chronic childhood asthma detected by oral challenge. Pediatrics 56:443–450PubMedGoogle Scholar
  88. Rosenhall L (1977) Hypersensitivity to analgesics, preservatives and food colorants in patients with asthma or rhinitis. Acta Univ 269:1–117Google Scholar
  89. Rosenoer VM, Tornay AS (1979) Drugs and the liver. Med Clin North Am 63:405–412PubMedGoogle Scholar
  90. Roth GJ, Stanford N, Majerus PW (1975) Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA 72:3073–3078PubMedGoogle Scholar
  91. Rudzki E (1977) Chronic urticaria due to aspirin and food additives (In Polish). Przegl Dermatol 64:163–166PubMedGoogle Scholar
  92. Samter M (1973) Intolerance to aspirin. Hosp Pract 8:85–90Google Scholar
  93. Samter M, Beers RJ Jr (1968) Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med 68:975–983PubMedGoogle Scholar
  94. Samuelsson B (1979) Oxygenation and further transformation of polyunsaturated fatty acids. Plenary Lecture at the IVth International Prostaglandin Conference, Washington, DC, May 1979Google Scholar
  95. Schlumberger HD, Löbbecke EA, Kallos P (1974) Acetylsalicylic acid intolerance. Acta Med Scand 196:451–458PubMedGoogle Scholar
  96. Schuhl JF, Pereyra JG (1979) Oral acetylsalicylic acid (aspirin) in asthmatic children. Clin Allergy 9:83–88PubMedGoogle Scholar
  97. Seaman WE, Ishak KG, Plotz PH (1974) Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus. Ann Intern Med 80:1–8PubMedGoogle Scholar
  98. Serwonska M (1979) Non-acidic nonsteroidal anti-inflammatory drugs and aspirin-induced asthma (In Polish). PhD thesis, University of CracowGoogle Scholar
  99. Settipane GA, Chafee FH, Klein DE (1974) Aspirin intolerance. II. A prospective study in atopic and normal population. J Allergy Clin Immunol 53:200–204PubMedGoogle Scholar
  100. Settipane GA, Chafee FH, Postman IM et al. (1976) Significance of tartrazine sensitivity in chronic urticaria of unknown etiology. J Allergy Clin Immunol 57:541–546PubMedGoogle Scholar
  101. Shen TY (1979) Prostaglandin synthetase inhibitors. In: Vane JR, Ferreira S (eds) Anti-inflammatory drugs. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 50/2, pp 305–347)Google Scholar
  102. Siegel MI, McConnel RT, Cuatrecasas P (1979) Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway. Proc Natl Acad Sci USA 76:3774–3778PubMedGoogle Scholar
  103. Slapke J, Jäger L (1979) Untersuchungen zum Analgetika-Asthma. Gesellschaft Inn Med DDR 34:78–80Google Scholar
  104. Smith JB, Willis AL (1971) Aspirin selectively inhibits prostaglandin production in human platlets. Nature New Biol 231:235–237PubMedGoogle Scholar
  105. Smith LJ, Slavin RG (1976) Drugs containing tartrazine dye. J Allergy Clin Immunol 58:456–470PubMedGoogle Scholar
  106. Sonnenblick M, Abraham AS (1978) Ibuprofen hypersensitivity in systemic lupus erythematosus. Br Med J 1:618–619Google Scholar
  107. Spühler O, Zollinger HU (1953) Die chronisch-interstitielle Nephritis. Z Klin Med 151:1–50PubMedGoogle Scholar
  108. Starr WR (1971) Familial aspirin hypersensitivity. Ann Allergy 29:498PubMedGoogle Scholar
  109. Stenius BSM, Lemola M (1976) Hypersensitivity to acetylsalicylic acid (ASA) and tartrazine in patients with asthma. Clin Allergy 6:119–129PubMedGoogle Scholar
  110. Stevenson DD, Arroyave CM, Bhat KN, Tan EM (1976) Oral aspirin challenge in asthmatic patients: a study of plasma histamine. Clin Allergy 6:493–506PubMedGoogle Scholar
  111. Szczeklik A (1980) Analgesics, allergy and asthma. Br J Clin Pharacol 10:401–405Google Scholar
  112. Szczeklik A, Czerniawska-Mysik G (1976) Prostaglandins and aspirin-induced asthma. Lancet 1:488Google Scholar
  113. Szczeklik A, Serwonska M (1979) Inhibition by clemastine of adverse reactions to aspirin in patients with asthma and aspirin idiosyncrasy. Thorax 34:654–657PubMedGoogle Scholar
  114. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G (1974) Is aspirin-sensitive asthma due to inhibition of prostaglandin synthesis? In: Proceedings of the Ninth European Congress of Allergy and Clinical Immunology, London, 1974, p 34Google Scholar
  115. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G (1975 a) Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1:67–69PubMedGoogle Scholar
  116. Szczeklik, A, Musial J, Serwonska M (1975 b) The effect of aspirin on bleeding time and platelet aggregation in patients hypersensitivity to nonsteroidal anti-inflammatory drugs. Abstracts of the XIth Congress of the Polish Society of Haematologists. Gdansk, p64Google Scholar
  117. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G, Zmuda A (1976) Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action to prostaglandin generation by different microsomal enzymic preparations. J Allergy Clin Immunol 58:10–18PubMedGoogle Scholar
  118. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G (1977 a) Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 60:276–284PubMedGoogle Scholar
  119. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G, Pieton R (1977 b) Asthmatic attacks induced in aspirin-sensitive patients by diclofenac and naproxen. Br Med J 2:231–232PubMedGoogle Scholar
  120. Szczeklik A, Gryglewski RJ, Olszewski E, Dembinska-Kiec A, Czerniawska-Mysik G (1977 c) Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps. Pharmacol Res Commun 9:415–425PubMedGoogle Scholar
  121. Szczeklik A, Nizankowska E, Nizankowski R (1977d) Bronchial reactivity to prostaglandin F2, E2, and histamine in different types of asthma, Respiration 34:323–331PubMedGoogle Scholar
  122. Szczeklik A, Gryglewski RJ, Nizankowska E (1978 a) Asthma relieved by aspirin and by other cyclo-oxygenase inhibitors. Thorax 33:664–665PubMedGoogle Scholar
  123. Szczeklik A, Gryglewski RJ, Nizankowska E, Nizankowski R, Musia I (1978b) Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man. Prostaglandins 16:651–660Google Scholar
  124. Szczeklik A, Gryglewski RJ, Nizankowska E (1979 a) Asthma improved by nonsteroidal anti-inflammatory drugs. Ann Intern Med 90:126–127PubMedGoogle Scholar
  125. Szczeklik A, Gryglewski RJ, Grodzinska L, Musia J, Serwonska M, Marcinkiewicz E (1979b) Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man. Throm Res 15:405–413Google Scholar
  126. Szczeklik A, Czerniawska-Mysik G, Serwonska M, Kuklinski P (1980) Inhibition by ketotifen of idiosyncratic reactions to aspirin. Allergy 35:421–424PubMedGoogle Scholar
  127. Trautlein J, Mann WJ (1978) Anaphylactic shock caused by yellow dye in an enema (case report). Ann Allergy 41:28–29PubMedGoogle Scholar
  128. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biol 231:232–235PubMedGoogle Scholar
  129. Vane JR (1976) The mode of action of aspirin and similar compounds. J Allergy Clin Immunol 58:691–712PubMedGoogle Scholar
  130. Van Leeuwen WS (1928) Pathognomonische Bedeutung der Überempfindlichkeit gegen Aspirin bei Asthmatikern. MMW 75:1588–1592Google Scholar
  131. Vedenthan PK, Menon MM, Bell TB, Bergin D (1977) Aspirin and tartrazine oral challenge: Incidence of adverse response in chronic childhood asthma. J Allergy Clin Immunol 60:8–13Google Scholar
  132. Virchow C (1976) Analgetika-Intoleranz bei Asthmatikern (Analgetika-Asthma-Syndrom). Prax Klin Pneumol 30:684–692Google Scholar
  133. Von Maur K, Adkinson NF, Van Metre TE, Marsh DG, Norman PS (1974) Aspirin intolerance in a family. J Allergy Clin Immunol 54:380–395Google Scholar
  134. Warin RP (1960) The effect of aspirin in chronic urticaria. Br J Dermatol 72:350–351PubMedGoogle Scholar
  135. Warin RP, Smith RJ (1976) Challenge test battery in chronic urticaria. Br J Dermatol 94:401–406PubMedGoogle Scholar
  136. Whittle BJR (1977) Prostaglandins and mast cell histamine release. NATO Adv Study Inst Ser Life Sci:345–351Google Scholar
  137. Woodbury DM, Fingl E (1979) Analgesic-antipyretics, anti-inflammatory agents, and drugs employed in the therapy of gout. In: Goodman LS, Gillman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 325–358Google Scholar
  138. Wuethrich B (1979) Protective effect of ketotifen and disodium cromoglycate against bronchoconstriction induced by aspirin, benzoic acid or tartrazine in intolerant asthmatics. Respiration 37:224–227Google Scholar
  139. Yurchak WM, Wicher K, Arbesman CE (1970) Immunologi studies on aspirin. J Allergy 46:245–252PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • A. Szczeklik

There are no affiliations available

Personalised recommendations